# Effect of Prolonged PDE-5 Inhibition on Insulin Signaling in Skeletal Muscle.

> **NCT02129725** · PHASE4 · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 15 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DRUG:** Sildenafil citrate
- **DRUG:** Placebo Oral Capsule

## Key facts

- **NCT ID:** NCT02129725
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2016-10
- **Final completion:** 2016-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02129725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02129725, "Effect of Prolonged PDE-5 Inhibition on Insulin Signaling in Skeletal Muscle.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02129725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*